View in EDS HTML Full Text PDF Full Text

lncRNA HIF1A-AS2 acts as an oncogene to regulate malignant phenotypes in cervical cancer.

Saved in:
Bibliographic Details
Title: lncRNA HIF1A-AS2 acts as an oncogene to regulate malignant phenotypes in cervical cancer.
Authors: Liu Y; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China.; Department of Clinical Laboratory, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China., Zhang Y; Department of Pediatric Dentistry, Affiliated Hospital of Guangzhou Medical University, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, Guangdong, China., Chen C; Department of Clinical Laboratory, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Roy B; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Qiantang District, Hangzhou, Zhejiang, China., Li Q; Department of Clinical Laboratory, Guangzhou Liwan District People's Hospital, Guangzhou, Guangdong, China., Zhang W; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China., Zhang X; Department of Clinical Laboratory, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Pu J; Department of Clinical Laboratory, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Li Y; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China., Liu Y; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China., Liao H; Department of Clinical Laboratory, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Wang J; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China., Zhou R; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China., Zhuo H; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China., Li Y; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China.
Source: Frontiers in oncology [Front Oncol] 2025 Feb 27; Vol. 15, pp. 1530677. Date of Electronic Publication: 2025 Feb 27 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40098697
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: lncRNA HIF1A-AS2 acts as an oncogene to regulate malignant phenotypes in cervical cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China.; Department of Clinical Laboratory, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Department of Pediatric Dentistry, Affiliated Hospital of Guangzhou Medical University, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Chen+C%22">Chen C</searchLink>; Department of Clinical Laboratory, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Roy+B%22">Roy B</searchLink>; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Qiantang District, Hangzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Li+Q%22">Li Q</searchLink>; Department of Clinical Laboratory, Guangzhou Liwan District People's Hospital, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Zhang+W%22">Zhang W</searchLink>; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Department of Clinical Laboratory, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Pu+J%22">Pu J</searchLink>; Department of Clinical Laboratory, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Liao+H%22">Liao H</searchLink>; Department of Clinical Laboratory, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Zhou+R%22">Zhou R</searchLink>; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Zhuo+H%22">Zhuo H</searchLink>; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Clinical Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, Guangdong, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Feb 27; Vol. 15, pp. 1530677. <i>Date of Electronic Publication: </i>2025 Feb 27 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40098697
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1530677
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1530677
    Titles:
      – TitleFull: lncRNA HIF1A-AS2 acts as an oncogene to regulate malignant phenotypes in cervical cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Chen C
      – PersonEntity:
          Name:
            NameFull: Roy B
      – PersonEntity:
          Name:
            NameFull: Li Q
      – PersonEntity:
          Name:
            NameFull: Zhang W
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Pu J
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Liao H
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Zhou R
      – PersonEntity:
          Name:
            NameFull: Zhuo H
      – PersonEntity:
          Name:
            NameFull: Li Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 02
              Text: 2025 Feb 27
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1